Related Experiment Video

Updated: Jun 5, 2026

Modified In Vivo Matrix Gel Plug Assay for Angiogenesis Studies
09:03

Modified In Vivo Matrix Gel Plug Assay for Angiogenesis Studies

Published on: June 30, 2023

Wnt pathway antagonists and angiogenesis

Bin Zhang1, Jian-Xing Ma

  • 1Department of Physiology, The University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA.

Protein & Cell
|January 5, 2011
PubMed

Insights

Wnt pathway antagonists show therapeutic promise for neovascular disorders by inhibiting pathological angiogenesis. This review explores their roles, mechanisms, and potential in treating angiogenic diseases.

Area of Science:

  • Molecular Biology
  • Pathology
  • Pharmacology

Background:

  • Dysregulation of the Wnt pathway is implicated in various diseases, including angiogenic disorders.
  • Wnt signaling activation promotes pathological angiogenesis, suggesting Wnt antagonists as potential therapeutics.
  • Wnt antagonists have been identified within the anti-angiogenic factor family.

Purpose of the Study:

  • To review recent advancements in understanding Wnt pathway antagonists.
  • To elucidate the mechanisms of action of Wnt antagonists in angiogenic regulation.
  • To explore the therapeutic potential of Wnt antagonists for neovascular disorders.

Main Methods:

  • Literature review of recent scientific publications.
  • Analysis of studies on Wnt pathway signaling in angiogenesis.
  • Examination of identified Wnt antagonists and their properties.

Main Results:

  • Wnt pathway antagonists play a crucial role in regulating angiogenesis.
  • Specific Wnt antagonists exhibit anti-angiogenic properties through various mechanisms.
  • Evidence supports the therapeutic potential of Wnt antagonists in neovascular conditions.

Conclusions:

  • Wnt pathway antagonists are key regulators of angiogenesis.
  • Targeting the Wnt pathway with antagonists offers a promising therapeutic strategy for angiogenic disorders.
  • Further research into Wnt antagonists could lead to novel treatments for neovascular diseases.

More Related Videos

The Soft Agar Colony Formation Assay08:01

The Soft Agar Colony Formation Assay

Published on: October 27, 2014

Related Concept Videos

Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...